AYUSH-QOL-2C To Reduce Side Effects

IAS Prelims 2023

The Central Council for Research in Ayurvedic Sciences (CCRAS) has developed an anti-diabetic drug AYUSH-82.

License has been granted to eight firms through National Research Development Corporation (NRDC) for commercialization.

CCRAS has developed a coded formulation AYUSH-QOL-2C to minimize side effects of Chemo and radiotherapy to improve quality of life in cancer patients.

The Central Council for Research in Homoeopathy (CCRH) has undertaken study to assess usefulness of Homoeopathic medicine in cancer patients having side effects from Chemotherapy.

The Central Council for Research in Yoga and Naturopathy (CCRYN) organises Yoga and Diabetes awareness programme through Government and Non-Government organizations.